| __timestamp | Biogen Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 2232342000 | 91733000 |
| Thursday, January 1, 2015 | 2113100000 | 87644000 |
| Friday, January 1, 2016 | 1947900000 | 92365000 |
| Sunday, January 1, 2017 | 1935500000 | 85656000 |
| Monday, January 1, 2018 | 2106300000 | 88196000 |
| Tuesday, January 1, 2019 | 2374700000 | 89971000 |
| Wednesday, January 1, 2020 | 2504500000 | 93413000 |
| Friday, January 1, 2021 | 2674300000 | 91355000 |
| Saturday, January 1, 2022 | 2403600000 | 113676000 |
| Sunday, January 1, 2023 | 2549700000 | 198366000 |
| Monday, January 1, 2024 | 2403700000 | 218935000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic planning. Over the past decade, Biogen Inc. and Taro Pharmaceutical Industries Ltd. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Biogen's SG&A expenses have seen a steady increase, peaking in 2021 with a 38% rise from 2014. In contrast, Taro's spending remained relatively stable until a notable surge in 2023, marking a 116% increase from 2014. This divergence highlights Biogen's aggressive investment in administrative capabilities, while Taro's recent spike suggests a strategic shift. Missing data for Biogen in 2024 indicates potential reporting delays or strategic changes. These insights provide a window into the companies' operational strategies, reflecting broader industry trends.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Biogen Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Biogen Inc.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.